From Casetext: Smarter Legal Research

Crosby v. Boehringer Ingelheim Pharm., Inc.

UNITED STATES DISTRICT COURT FOR THE WESTERN DISTRICT OF MISSOURI WESTERN DIVISION
Mar 24, 2021
No. 4:19-cv-00611-DGK (W.D. Mo. Mar. 24, 2021)

Opinion

No. 4:19-cv-00611-DGK

03-24-2021

GERALDINE CROSBY, Plaintiff, v. BOEHRINGER INGELHEIM PHARMACEUTICALS, INC., Defendant.


ORDER DENYING MOTION FOR SUMMARY JUDGMENT WITHOUT PREJUDICE AND STAYING CASE

Plaintiff Geraldine Crosby allegedly suffered injuries after using Pradaxa, a pharmaceutical manufactured, designed, distributed, sold, and supplied by Defendant Boehringer Ingelheim Pharmaceuticals ("BI"). Now before the Court is BI's motion for summary judgment. ECF No. 44. Defendant argues United States Food and Drug Administration regulations preempt Plaintiff's claims under Mo. Ann. Stat. § 537.760 and Missouri common law for damages arising from Plaintiff's use of Pradaxa.

Defendant relies on Ridings v. Maurice, 444 F. Supp. 3d 973 (W.D. Mo. 2020), to support its contention that Plaintiff's claims are preempted. In Ridings, a federal magistrate judge granted summary judgment in favor of the defendants on the basis that similar claims were preempted by FDA regulation. Id. The Ridings plaintiff appealed the issue of federal preemption. See Ridings v. Boehringer Ingelheim Pharms., No. 20-1824 (8th Cir. filed April 17, 2020). The parties to this case agree that a ruling on the Ridings appeal may be dispositive to Defendant's motion for summary judgment. On November 12, 2020, the Eighth Circuit stayed the Ridings appeal pending a potential global settlement agreement. Clerk Order, Ridings v. Boehringer Ingelheim Pharms., No. 20-1824.

BI was also a defendant in Ridings v. Maurice. 444 F. Supp 3d at 977. --------

On November 9, 2020, the parties jointly requested a stay in this case to finalize a global settlement agreement. ECF No. 70. The Court denied the motion without prejudice out of concern that granting the stay would force the Court to reschedule trial—currently set for November 1, 2021—if the parties are unable to reach a final agreement. ECF No. 71.

Because the Eighth Circuit is unlikely to rule on the Ridings appeal before this case is scheduled for trial, the Court has reconsidered its decision. Clinton v. Jones, 520 U.S. 681, 707 (1997) ("The District Court has broad discretion to stay proceedings as an incident to its power to control its own docket."). This case is STAYED, and the parties shall issue a joint stipulation of dismissal or a status update on or before August 1, 2021. Defendant's motion for summary judgment is DENIED WITHOUT PREJUDICE.

IT IS SO ORDERED. Date: March 24, 2021

/s/ Greg Kays

GREG KAYS, JUDGE

UNITED STATES DISTRICT COURT


Summaries of

Crosby v. Boehringer Ingelheim Pharm., Inc.

UNITED STATES DISTRICT COURT FOR THE WESTERN DISTRICT OF MISSOURI WESTERN DIVISION
Mar 24, 2021
No. 4:19-cv-00611-DGK (W.D. Mo. Mar. 24, 2021)
Case details for

Crosby v. Boehringer Ingelheim Pharm., Inc.

Case Details

Full title:GERALDINE CROSBY, Plaintiff, v. BOEHRINGER INGELHEIM PHARMACEUTICALS…

Court:UNITED STATES DISTRICT COURT FOR THE WESTERN DISTRICT OF MISSOURI WESTERN DIVISION

Date published: Mar 24, 2021

Citations

No. 4:19-cv-00611-DGK (W.D. Mo. Mar. 24, 2021)